The Latest Cardiac and Vascular News
MIAMI, April 1, 2022 /PRNewswire/ — East End Medical, a private medical device company committed to improving catheter-based cardiac procedures, today announced the first commercial uses of its SafeCross™ Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The All-in-One system is designed to provide a predictable and safe solution for performing electrophysiology and […]
New collaboration to deliver information and resources targeted to the needs of physicians throughout Latin America NEW YORK, April 1, 2022 /PRNewswire/ — Medscape and the American College of Cardiology (ACC) today announced the launch of the Latin America Center for Cardiovascular Health Promotion (Spanish and Portuguese), a new collaboration that will deliver trusted scientific information and […]
HANGZHOU, China, March 31, 2022 /PRNewswire/ — On March 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as “Venus Medtech”), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced its annual results for the year ended December 31, 2021. According to the financial report, Venus Medtech recorded RMB416 […]
Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of EPA/atorvastatin active metabolite (ATM) and of EPA/rosuvastatin (rosuva) reduced lipid oxidation by 86% and 75%, respectively (p<0.001) DUBLIN, Ireland and BRIDGEWATER, N.J., April 01, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc […]
SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare, a division of OSI Systems, Inc. (“OSI Systems”), today announced that it will be demonstrating new diagnostic cardiology products at the American College of Cardiology’s (“ACC”) 71st annual event. Attendees will have an opportunity to see new and recent offerings from Spacelabs Healthcare, including the Eclipse™ Pro […]
IRVINE, Calif., March 31, 2022 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart’s mitral position. The MITRIS RESILIA valve has a saddle-shaped sewing cuff that mimics the asymmetric […]
IRVING, Texas–(BUSINESS WIRE)–In its latest Medical Device Tech Watch, Vizient, Inc. provides updated trends in patient quality outcomes for transcatheter valve replacement, including insights for complications and physician expertise. In addition, this issue presents a technology adoption model for assessing the clinical and financial impact of various technologies in musculoskeletal care. The […]
CathWorks FFRangio™ System outcomes study to be presented at ACC 2022 CathWorks announces the completion of more than 5,000 FFRangio cases globally KFAR-SABA, Israel and IRVINE, Calif., March 31, 2022 /PRNewswire/ — CathWorks announced today that the results of its most recent outcomes study on the CathWorks FFRangio™ system will be presented by Dr. Guy Witberg from Rabin Medical […]
PALM SPRINGS, Calif. and MOUNTAIN VIEW, Calif., March 31, 2022 /PRNewswire/ — Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, and Lark Health today announced that DOHC will offer Lark Heart Health, a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease (CAD). Together, DOHC and Lark will […]
PARIS, March 31, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announced the publication of a new scientific article reporting the efficacy of its second drug-candidate, […]
